Coronavirus disease 2019 (COVID-19) breakthrough infection and post-vaccination neutralizing antibodies among healthcare workers in a referral hospital in Tokyo: a …
…, K Maeda, K Matsuda, A Tanaka, K Horii… - Clinical Infectious …, 2022 - academic.oup.com
Background While increasing coverage of effective vaccines against coronavirus disease
2019 (COVID-19), emergent variants raise concerns about breakthrough infection. Data are …
2019 (COVID-19), emergent variants raise concerns about breakthrough infection. Data are …
[HTML][HTML] Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine
…, Y Oshiro, N Inamura, T Nemoto, K Horii… - Clinical Microbiology …, 2023 - Elsevier
Objectives To examine the differences in durability and its determinants of humoral immunity
following 2- and 3-dose COVID-19 vaccination. Methods Throughout the pandemic, we …
following 2- and 3-dose COVID-19 vaccination. Methods Throughout the pandemic, we …
[HTML][HTML] Omicron BA. 1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
…, T Mizoue, M Konishi, JS Takeuchi, K Horii… - BMC Infectious …, 2023 - Springer
Background Longitudinal data are lacking to compare booster effects of Delta breakthrough
infection versus third vaccine dose on neutralizing antibodies (NAb) against Omicron. …
infection versus third vaccine dose on neutralizing antibodies (NAb) against Omicron. …
[HTML][HTML] Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave
S Yamamoto, K Matsuda, K Maeda, K Horii… - International Journal of …, 2023 - Elsevier
Objectives To investigate the role of immunogenicity after the third vaccine dose against
Omicron infection and COVID-19-compatible symptoms of infection. Methods First, we examined …
Omicron infection and COVID-19-compatible symptoms of infection. Methods First, we examined …
Preinfection Neutralizing Antibodies, Omicron BA. 5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis
…, K Matsuda, K Maeda, K Horii… - The Journal of …, 2023 - academic.oup.com
Background Data are limited on the role of preinfection humoral immunity protection against
Omicron BA.5 infection and long coronavirus disease (COVID) development. Methods We …
Omicron BA.5 infection and long coronavirus disease (COVID) development. Methods We …
Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants
…, Y Oshiro, N Inamura, T Nemoto, K Horii… - Epidemiology & …, 2023 - cambridge.org
To describe the trend of cumulative incidence of coronavirus disease 19 (COVID-19) and
undiagnosed cases over the pandemic through the emergence of severe acute respiratory …
undiagnosed cases over the pandemic through the emergence of severe acute respiratory …
“Syndromic surveillance within a hospital” for the early detection of a nosocomial outbreak of acute respiratory infection
…, J Sekiguchi, Y Kato, E Kuroda, K Horii… - Japanese journal of …, 2006 - jstage.jst.go.jp
We have performed intra-hospital syndromic surveillance to rapidly detect nosocomial acute
respiratory infection outbreaks in both inpatients and health care workers in a hospital. …
respiratory infection outbreaks in both inpatients and health care workers in a hospital. …
[HTML][HTML] Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants
…, N Inamura, T Nemoto, M Ozeki, K Horii… - The Journal of …, 2022 - ncbi.nlm.nih.gov
Fig. 1. Setting of the restaurant.(A) Floor plan;(B) image obtained from the video camera. out
both close contact and fomite routes. In this specific context, we found that close contact …
both close contact and fomite routes. In this specific context, we found that close contact …
Protection of Omicron bivalent vaccine, previous infection, and their induced neutralizing antibodies against symptomatic infection with Omicron XBB. 1.16 and EG. 5.1
S Yamamoto, K Matsuda, K Maeda, T Mizoue, K Horii… - medRxiv, 2024 - medrxiv.org
Background Data are limited on the protective role of the Omicron BA bivalent vaccine,
previous infection, and their induced neutralizing antibodies against Omicron XBB.1.16 and EG.…
previous infection, and their induced neutralizing antibodies against Omicron XBB.1.16 and EG.…
A novel protocol for de-isolating moderately and severely immunocompromised COVID-19 patients
…, M Ishikane, K Yamamoto, K Horii… - Global Health & …, 2023 - jstage.jst.go.jp
Immunocompromised coronavirus disease 2019 patients are at a higher risk of prolonged
viral shedding than immunocompetent patients. However, as of August 2023, there is no clear …
viral shedding than immunocompetent patients. However, as of August 2023, there is no clear …